{"name":"Gary L. Pierce","slug":"gary-l-pierce","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Umeclidinium / Vilanterol Dry Powder Inhaler","genericName":"Umeclidinium / Vilanterol Dry Powder Inhaler","slug":"umeclidinium-vilanterol-dry-powder-inhaler","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Experimental: Nitrate-containing","genericName":"Experimental: Nitrate-containing","slug":"experimental-nitrate-containing","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Umeclidinium / Vilanterol Dry Powder Inhaler","genericName":"Umeclidinium / Vilanterol Dry Powder Inhaler","slug":"umeclidinium-vilanterol-dry-powder-inhaler","phase":"marketed","mechanism":"Umeclidinium is a long-acting anticholinergic that blocks muscarinic receptors to relax airway smooth muscle, while vilanterol is a long-acting beta-2 agonist that further dilates airways; together they provide sustained bronchodilation for COPD.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"Experimental: Nitrate-containing","genericName":"Experimental: Nitrate-containing","slug":"experimental-nitrate-containing","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNYUFNN2dvc0F4WUZxQ1g1WjZvakhzOGdybEtncXRacW1Sa1c3V1RPd2czSk51TU44NGhjbXZNaDdrejFpNkRFTFhvQ01iOEE0c0l5WUgxNDdlMG0wTnp6aVU0aHJVYVJKV2JjLTJkeXJ5dWdVbnNxUjRPaXRnVVZZbURxNUJVem1jTkM2Qks2ZjNPaXAtdkFEZGc0eU5MQUx6eHFiNlhHSzA1d25LSEhrNXQ1emNFRjlKOFRmaVZXbG4wbVh5VS11RTUwcVBnZWNhME9XcVQ3dzdHbnJQT1E?oc=5","date":"2019-07-27","type":"pipeline","source":"Sun Sentinel","summary":"5.6 billion opioid pills flooded the state, and rogue South Florida doctors helped get them on the streets - Sun Sentinel","headline":"5.6 billion opioid pills flooded the state, and rogue South Florida doctors helped get them on the streets","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}